Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × azaspirane × Clear all

NCT00663429 2011-08-31

Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma

Phase 2 Completed

Carcinoma, Neuroendocrine

NCT00388063 2007-12-21

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Phase 2 Completed

Carcinoid Tumor, Carcinoma, Carcinoma, Neuroendocrine